Treatment for Specific Multiple Sclerosis (MS) Symptoms
While some scientists look for therapies that will affect the overall
course of the disease, others are searching for new and better medications to control the
symptoms of multiple sclerosis (MS) without triggering intolerable side effects.
Many people with MS have problems with spasticity, a condition that primarily affects the
lower limbs. Spasticity can occur either as a sustained stiffness caused by increased
muscle tone or as spasms that come and go, especially at night. It is usually treated with
muscle relaxants and tranquilizers. Baclofen (Lioresal), the most commonly prescribed
medication for this symptom, may be taken orally or, in severe cases, injected into the
spinal cord. Tizanidine (Zanaflex), used for years in Europe and now approved in the
United States, appears to function similarly to baclofen. Diazepam (Valium), clonazepam
(Klonopin), and dantrolene (Dantrium) can also reduce spasticity. Although its beneficial
effect is temporary, physical therapy may also be useful and can help prevent the
irreversible shortening of muscles known as contractures. Surgery to reduce spasticity is
rarely appropriate in MS.
Weakness and ataxia (incoordination) are also characteristic of MS. When weakness is a
problem, some spasticity can actually be beneficial by lending support to weak limbs. In
such cases, medication levels that alleviate spasticity completely may be inappropriate.
Physical therapy and exercise can also help preserve remaining function, and patients may
find that various aids--such as foot braces, canes, and walkers--can help them remain
independent and mobile. Occasionally, physicians can provide temporary relief from
weakness, spasms, and pain by injecting a drug called phenol into the spinal cord,
muscles, or nerves in the arms or legs. Further research is needed to find or develop
effective treatments for MS-related weakness and ataxia.
Although improvement of optic symptoms usually occurs even without treatment, a short
course of treatment with intravenous methylprednisolone (Solu-Medrol) followed by
treatment with oral steroids is sometimes used. A trial of oral prednisone in patients
with visual problems suggests that this steroid is not only ineffective in speeding
recovery but may also increase patients' risk for future MS attacks. Curiously, prednisone
injected directly into the veins--at ten times the oral dose--did seem to produce
short-term recovery. Because of the link between optic neuritis and MS, the study's
investigators believe these findings may hold true for the treatment of MS as well. A
follow-up study of optic neuritis patients will address this and other questions.
Fatigue, especially in the legs, is a common symptom of MS and may be both physical and
psychological. Avoiding excessive activity and heat are probably the most important
measures patients can take to counter physiological fatigue. If psychological aspects of
fatigue such as depression or apathy are evident, antidepressant medications may help.
Other drugs that may reduce fatigue in some, but not all, patients include amantadine
(Symmetrel), pemoline (Cylert), and the still-experimental drug aminopyridine.
People with MS may experience several types of pain. Muscle and back pain can be helped by
aspirin or acetaminophen and physical therapy to correct faulty posture and strengthen and
stretch muscles. The sharp, stabbing facial pain known as trigeminal neuralgia is commonly
treated with carbamazapine or other anticonvulsant drugs or, occasionally, surgery.
Intense tingling and burning sensations are harder to treat. Some people get relief with
antidepressant drugs; others may respond to electrical stimulation of the nerves in the
affected area. In some cases, the physician may recommend codeine.
As the disease progresses, some patients develop bladder malfunctions. Urinary problems
are often the result of infections that can be treated with antibiotics. The physician may
recommend that patients take vitamin C supplements or drink cranberry juice, as these
measures acidify urine and may reduce the risk of further infections. Several medications
are also available. The most common bladder problems encountered by MS patients are
urinary frequency, urgency, or incontinence. A small number of patients, however, retain
large amounts of urine. In these patients, catheterization may be necessary. In this
procedure, a catheter or drainage tube is temporarily inserted (by the patient or a
caretaker) into the urethra several times a day to drain urine from the bladder. Surgery
may be indicated in severe, intractable cases. Scientists have developed a "bladder
pacemaker" that has helped people with urinary incontinence in preliminary trials.
The pacemaker, which is surgically implanted, is controlled by a hand-held unit that
allows the patient to electrically relax the nerves used for urine retention or contract
those needed to empty the bladder.
MS patients with urinary problems may be reluctant to drink enough fluids, leading to
constipation. Drinking more water and adding fiber to the diet usually alleviates this
condition. Sexual dysfunction may also occur, especially in patients with urinary
problems. Men may experience occasional failure to attain an erection. Penile implants,
injection of the drug papaverine, and electrostimulation are techniques used to resolve
the problem. Women may experience insufficient lubrication or have difficulty reaching
orgasm; in these cases, vaginal gels and vibrating devices may be helpful. Counseling is
also beneficial, especially in the absence of urinary problems, since psychological
factors can also cause these symptoms. For instance, depression can intensify symptoms of
fatigue, pain, and sexual dysfunction. In addition to counseling, the physician may
prescribe antidepressant or antianxiety medications. Amitriptyline is used to treat
laughing/weeping syndrome.
Tremors are often resistant to therapy, but can sometimes be treated with drugs or, in
extreme cases, surgery. Investigators are currently examining a number of experimental
treatments for tremor.
Information provided by the
National Institutes of Health
Article Created: 2000-03-29 Article Updated: 2000-03-29
Each year, Medical College of Wisconsin physicians care for more than 180,000 patients, representing nearly 500,000 patient visits. Medical College physicians practice at Children's Hospital of Wisconsin, Froedtert Memorial Lutheran Hospital, the Milwaukee VA Medical Center, and many other hospitals and clinics in Milwaukee and southeastern Wisconsin.
|